Although numerous studies have been able to establish the importance of Th17 cells and their associated IL-17 in RA thereby making it a potential therapeutic target of interest, IL-17 inhibition has not delivered the hoped-for results. This evidence concerns the gene IL17A and rheumatoid arthritis.